Raymond Fong, M.D.

Leading Expert in Vision Correction for Asian Eyes
Dr. Raymond Fong is a highly regarded ophthalmologist specializing in vision correction for Asian eyes, acknowledging the unique anatomic differences and requirements in treating this demographic. With extensive experience in LASIK, EVO ICL™, and cataract surgery, Dr. Fong has performed over 60,000 surgeries and is recognized as a pioneer in this specialized field.

Founder of Raymond Fong Eye Care

Dr. Raymond Fong graduated with honors from Harvard and went on to attend Cornell Medical School. As a Board-Certified Fellow of the American Academy of Ophthalmology, Dr. Fong has performed over 45,000 cataract surgeries, more than 20,000 LASIK procedures, and over 45,000 other laser treatments.

An active community participant, Dr. Fong previously served as President of the Chinese American Medical Society and is the current Chairman of the Chinatown Health Clinic Foundation, a nonprofit committed to providing healthcare for underserved and immigrant populations.

Recognized as one of the top doctors in The Best Doctors–New York Metro Area (published by Castle Connolly Medical Ltd.) since 1993, Dr. Fong leads one of New York City’s largest cataract and LASIK practices. He is the Director of the New York Eye Surgical Center and the Brooklyn Eye Surgery Center. Additionally, he co-founded and serves as Director of one of the five LASIK centers in the U.S.—the first in New York City to receive Alcon Center of Excellence recognition.

Dr. Fong is also regarded as a Key Opinion Leader (KOL) in ophthalmology. He has served as a consultant and speaker for leading global surgical and pharmaceutical companies, including Alcon and Bausch & Lomb. Furthermore, he has been a principal investigator in numerous FDA clinical trials, allowing him to integrate cutting-edge treatments and innovations into his practice.

Personal Statement

Born in Hong Kong and raised in New York City’s Chinatown, where both of my parents worked tirelessly in garment factories six days a week, I have a deep understanding of the challenges many of my patients face. It is a privilege to return and serve this community that shaped me. On a personal level, this community is more than just where I work—it is my home.

There is no greater professional joy than caring for my friends and their families: parents, grandparents, uncles, aunts, and children. This community is my family, and in my practice, each patient is treated as such. It is my commitment to stay at the forefront of medical advancements and provide only the most advanced and highest-quality care—because that is what my family deserves.

young college student with clear vision smiling

Dr Raymond Fong is an excellent surgeon with decades of experience. I went in for a LASIK procedure and I am absolutely loving the results. He, along with his team are extremely skilled, professional and friendly as well. They make you feel extremely confident going into the surgery and they keep you informed the entire way. If you are thinking of LASIK or any other eye procedure, I would absolutely recommend Dr. Raymond Fong for the excellent care you will receive.

Hunter

Publications & Presentations

Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample.
Robert Lehmann, Andrew Maxwell, David M Lubeck, Raymond Fong, Thomas R Walters, Anna Fakadej;Clin Ophthalmol. 20 April 2021 Volume 2021:15 Pages 1647—1657

Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery.
Fong, R.,Silverstein, B. E.,Peace, J. H.,Williams, J. I.,Vittitow, J. L. ;J Cataract Refract Surg. 2018 Sep 09

Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: Phase 3 study.
Modi, S. S.,Lehmann, R. P.,Walters, T. R.,Fong, R.,Christie, W. C.,Roel, L.,Nethery, D.,Sager, D.,Tsorbatzoglou, A.,Philipson, B.,Traverso, C. E.,Reiser, H.; J Cataract Refract Surg. 2013 Dec 19.

Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial.
Fong, R., Leitritz, M., Siou-Mermet, R., Erb, T.; Clin Ophthalmol. 2012.

 

Schedule a FREE LASIK or EVO ICL Consultation Today!

young female entrepreneur seeing the city with renewed vision